Optimal treatment of Imipenem and meropenem against bloodstream infections caused by the Citrobacter spp | BMC Infectious Diseases
Yao Y, Falgenhauer L, Falgenhauer J, Hauri AM, Heinmüller P, Domann E, Chakraborty T, Imirzalioglu C. Carbapenem-Resistant Citrobacter spp. As an emerging concern in the Hospital-Setting: results from a Genome-Based regional surveillance study. Front Cell Infect Microbiol. 2021;11:744431. https://doi.org/10.3389/fcimb.2021.744431 Article CAS PubMed PubMed Central Google Scholar Doran TI. The role of Citrobacter in clinical disease … Read more